Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Explaining the decline in coronary heart disease mortality in the Czech Republic between 1985 and 2007

J. Bruthans, R. Cífková, V. Lánská, M. O'Flaherty, JA. Critchley, J. Holub, P. Janský, J. Zvárová, S. Capewell,

. 2014 ; 21 (7) : 829-39. [pub] 20121124

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc16000828

BACKGROUND: Coronary heart disease (CHD) mortality has declined substantially in the Czech Republic over the last two decades. DESIGN: The purpose of this study was to determine what proportion of this CHD mortality decline could be associated with temporal trends in major CHD risk factors and what proportion with advances in medical and surgical treatments. METHODS: The validated IMPACT mortality model was used to combine and analyse data on uptake and effectiveness of CHD management and risk factor trends in the Czech Republic in adults aged 25-74 years between 1985 and 2007. The main sources were official statistics, national quality of care registries, published trials and meta-analyses, and the Czech MONICA and Czech post-MONICA studies. RESULTS: Between 1985 and 2007, age-adjusted CHD mortality rates in the Czech Republic decreased by 66.2% in men and 65.4% in women in the age group 25-74 years, representing 12,080 fewer CHD deaths in 2007. Changes in CHD risk factors explained approximately 52% of the total mortality decrease, and improvements in medical treatments approximately 43%. Increases in body mass index and in diabetes prevalence had a negative impact, increasing CHD mortality by approximately 1% and 5%, respectively. CONCLUSIONS: More than half of the very substantial fall in CHD mortality in the Czech Republic between 1985 and 2007 was attributable to reduction in major cardiovascular risk factors. Improvement in treatments accounted for approximately 43% of the total mortality decrease. These findings emphasize the value of primary prevention and evidence-based medical treatment.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16000828
003      
CZ-PrNML
005      
20160516103454.0
007      
ta
008      
160108s2014 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1177/2047487312469476 $2 doi
035    __
$a (PubMed)23180867
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Bruthans, Jan $u Department of Preventive Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic Department of Medicine II, Charles University Medical School, Pilsen, Czech Republic jan.bruthans@ikem.cz.
245    10
$a Explaining the decline in coronary heart disease mortality in the Czech Republic between 1985 and 2007 / $c J. Bruthans, R. Cífková, V. Lánská, M. O'Flaherty, JA. Critchley, J. Holub, P. Janský, J. Zvárová, S. Capewell,
520    9_
$a BACKGROUND: Coronary heart disease (CHD) mortality has declined substantially in the Czech Republic over the last two decades. DESIGN: The purpose of this study was to determine what proportion of this CHD mortality decline could be associated with temporal trends in major CHD risk factors and what proportion with advances in medical and surgical treatments. METHODS: The validated IMPACT mortality model was used to combine and analyse data on uptake and effectiveness of CHD management and risk factor trends in the Czech Republic in adults aged 25-74 years between 1985 and 2007. The main sources were official statistics, national quality of care registries, published trials and meta-analyses, and the Czech MONICA and Czech post-MONICA studies. RESULTS: Between 1985 and 2007, age-adjusted CHD mortality rates in the Czech Republic decreased by 66.2% in men and 65.4% in women in the age group 25-74 years, representing 12,080 fewer CHD deaths in 2007. Changes in CHD risk factors explained approximately 52% of the total mortality decrease, and improvements in medical treatments approximately 43%. Increases in body mass index and in diabetes prevalence had a negative impact, increasing CHD mortality by approximately 1% and 5%, respectively. CONCLUSIONS: More than half of the very substantial fall in CHD mortality in the Czech Republic between 1985 and 2007 was attributable to reduction in major cardiovascular risk factors. Improvement in treatments accounted for approximately 43% of the total mortality decrease. These findings emphasize the value of primary prevention and evidence-based medical treatment.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a koronární nemoc $x mortalita $7 D003327
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a statistické modely $7 D015233
650    _2
$a rizikové faktory $7 D012307
650    _2
$a senzitivita a specificita $7 D012680
651    _2
$a Česká republika $x epidemiologie $7 D018153
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Cífková, Renata $u Department of Preventive Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic Centre for Cardiovascular Prevention, Thomayer Hospital and Charles University Medical School I, Prague, Czech Republic Department of Medicine II, Charles University Medical School I, Prague, Czech Republic International Clinical Research Centre Brno, Czech Republic.
700    1_
$a Lánská, Věra $u Medical Statistics Unit, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
700    1_
$a O'Flaherty, Martin $u Division of Public Health, University of Liverpool, UK.
700    1_
$a Critchley, Julia A $u Institute of Health and Society, University of Newcastle, UK.
700    1_
$a Holub, Jiří $u Institute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic.
700    1_
$a Janský, Petr $u Department of Cardiovascular Surgery, Charles University Medical School II and Motol University Hospital, Prague, Czech Republic.
700    1_
$a Zvárová, Jana $u Centre of Biomedical Informatics, Institute of Computer Science, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
700    1_
$a Capewell, Simon $u Division of Public Health, University of Liverpool, UK.
773    0_
$w MED00188754 $t European journal of preventive cardiology $x 2047-4881 $g Roč. 21, č. 7 (2014), s. 829-39
856    41
$u https://pubmed.ncbi.nlm.nih.gov/23180867 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160108 $b ABA008
991    __
$a 20160516103604 $b ABA008
999    __
$a ok $b bmc $g 1103109 $s 925034
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 21 $c 7 $d 829-39 $e 20121124 $i 2047-4881 $m European journal of preventive cardiology $n Eur J Prev Cardiol $x MED00188754
LZP    __
$a Pubmed-20160108

Najít záznam

Citační ukazatele

Možnosti archivace